You have 9 free searches left this month | for more free features.

penpulimab

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Penpulimab
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Penpulimab
  • +3 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Penpulimab in Maintenance Therapy in Lymphoma

Not yet recruiting
  • Lymphoma
  • Penpulimab
  • (no location specified)
Dec 25, 2022

Breast Cancer Trial in Chengdu (Disitamab Vedotin, Penpulimab)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin
  • Penpulimab
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Feb 9, 2023

Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • Locally Advanced
  • Short-course radiotherapy
  • +3 more
  • (no location specified)
Oct 8, 2022

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Penpulimab
  • +3 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Primary CNS Lymphoma Trial (Penpulimab)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • Penpulimab
  • (no location specified)
Apr 20, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Anlotinib, Penpulimab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)

Recruiting
  • Thyroid Cancer
  • Anlotinib hydrochloride
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

Gynecological Cancer Trial in Beijing, Chengdu (Penpulimab, Anlotinib)

Not yet recruiting
  • Gynecological Cancer
  • Beijing, Beijing, China
  • +1 more
Dec 28, 2021

Colorectal Cancer Trial in China (Anlotinib, Penpulimab)

Recruiting
  • Colorectal Cancer
  • Beijing, Beijing, China
  • +7 more
Mar 6, 2022

Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)

Recruiting
  • Hodgkin Disease Lymphoma
  • Penpulimab
  • Investigator's choice of Chemotherapy
  • Guangzhou, Guangdong, China
  • +5 more
Feb 15, 2022

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023